The undersigned parties hereby agree that this Amendment No. 1 to Schedule 13D filed herewith relating to the American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share of Chemomab Therapeutics Ltd., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) on behalf of each such person.
Date: November 17, 2022
/s/ Adi Mor
ADI MOR
/s/ Kobi George
KOBI GEORGE
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
